Stock futures are moving higher this morning. Markets are shifting toward a more conditional relief trade, but energy prices are still dictating direction. The move is tied directly to a sharp pullback in crude oil, which dropped more than 4%-5% overnight on renewed hopes for a potential ceasefire framework between the U.S. and Iran. After several sessions where rising energy prices pressured equities and pushed yields higher, the reversal is easing inflation expectations at the margin. As a result, markets are beginning to reprice the path of interest rates slightly lower, which is providing near-term support for equities and risk assets.
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade FLYHowever, the improvement in sentiment is based on tentative headlines, not confirmed changes in supply dynamics or a finalized agreement. Iran has pushed back on reports of negotiations, and oil has already shown a tendency to rebound quickly when optimism fades. Rising Treasury yields and ongoing geopolitical uncertainty continue to cap upside, particularly for rate-sensitive sectors like technology.
In pre-market trading, S&P 500 futures rose 0.67%, Nasdaq futures rose 0.83% and Dow futures rose 0.68%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Arm (ARM) up 10% after reporting the company expects its own chips business to generate about $15B in annual sales in five years.
- Terns Pharmaceuticals (TERN) up 5% after entering into a definitive agreement under which Merck (MRK), through a subsidiary, will acquire Terns for $53.00 per share in cash
- Sturm Ruger (RGR) up 3% after Beretta Holding announced plans to launch a tender offer for up to 20.05% of Sturm Ruger shares at $44.80 per share
HIGHER AFTER REPORT OF ACCELERATED SPACEX IPO TIMELINE –
- EchoStar (SATS) up 5%
- Rocket Lab (RKLB) up 3%
- FireFly Aerospace (FLY) up 3%
- AST SpaceMobile (ASTS) up 2%
- Planet Labs (PL) up 2%
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
LOWER –
- Anavex (AVXL) down 32% after withdrawing its application for the marketing authorization of blarcamesine in the EU as an add-on therapy for the treatment of early Alzheimer’s disease in adults, which had been under review by the European Medicines Agency
- On Holding (ONON) down 4% after reporting Martin Hoffmann will step down as CEO
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARM:
- Video: Arm jumps as analysts react favorably to business model shift, guidance
- Arm price target raised to $175 from $130 at RBC Capital
- Arm price target raised to $240 from $201 at Guggenheim
- Arm 2031 outlook beat most bullish expectations, says Citi
- Arm upgraded to Outperform from Market Perform at Raymond James
